168 related articles for article (PubMed ID: 21147881)
1. Profiling of endogenous estrogens, their precursors, and metabolites in endometrial cancer patients: association with risk and relationship to clinical characteristics.
Audet-Walsh E; Lépine J; Grégoire J; Plante M; Caron P; Têtu B; Ayotte P; Brisson J; Villeneuve L; Bélanger A; Guillemette C
J Clin Endocrinol Metab; 2011 Feb; 96(2):E330-9. PubMed ID: 21147881
[TBL] [Abstract][Full Text] [Related]
2. Estradiol metabolites as biomarkers of endometrial cancer prognosis after surgery.
Audet-Delage Y; Grégoire J; Caron P; Turcotte V; Plante M; Ayotte P; Simonyan D; Villeneuve L; Guillemette C
J Steroid Biochem Mol Biol; 2018 Apr; 178():45-54. PubMed ID: 29092787
[TBL] [Abstract][Full Text] [Related]
3. Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women.
Lukanova A; Lundin E; Micheli A; Arslan A; Ferrari P; Rinaldi S; Krogh V; Lenner P; Shore RE; Biessy C; Muti P; Riboli E; Koenig KL; Levitz M; Stattin P; Berrino F; Hallmans G; Kaaks R; Toniolo P; Zeleniuch-Jacquotte A
Int J Cancer; 2004 Jan; 108(3):425-32. PubMed ID: 14648710
[TBL] [Abstract][Full Text] [Related]
4. Case-control study of endogenous steroid hormones and endometrial cancer.
Potischman N; Hoover RN; Brinton LA; Siiteri P; Dorgan JF; Swanson CA; Berman ML; Mortel R; Twiggs LB; Barrett RJ; Wilbanks GD; Persky V; Lurain JR
J Natl Cancer Inst; 1996 Aug; 88(16):1127-35. PubMed ID: 8757192
[TBL] [Abstract][Full Text] [Related]
5. Circulating estrogens in endometrial cancer cases and their relationship with tissular expression of key estrogen biosynthesis and metabolic pathways.
Lépine J; Audet-Walsh E; Grégoire J; Têtu B; Plante M; Ménard V; Ayotte P; Brisson J; Caron P; Villeneuve L; Bélanger A; Guillemette C
J Clin Endocrinol Metab; 2010 Jun; 95(6):2689-98. PubMed ID: 20371658
[TBL] [Abstract][Full Text] [Related]
6. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review.
Kaaks R; Lukanova A; Kurzer MS
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1531-43. PubMed ID: 12496040
[TBL] [Abstract][Full Text] [Related]
7. Serum concentrations of estrogens, sex hormone binding globulin, and androgens and risk of breast hyperplasia in postmenopausal women.
Schairer C; Hill D; Sturgeon SR; Fears T; Mies C; Ziegler RG; Hoover RN; Sherman ME
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1660-5. PubMed ID: 16030098
[TBL] [Abstract][Full Text] [Related]
8. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
[TBL] [Abstract][Full Text] [Related]
9. Joint effect of insulin-like growth factors and sex steroids on breast cancer risk.
Yu H; Shu XO; Li BD; Dai Q; Gao YT; Jin F; Zheng W
Cancer Epidemiol Biomarkers Prev; 2003 Oct; 12(10):1067-73. PubMed ID: 14578144
[TBL] [Abstract][Full Text] [Related]
10. Endogenous estrogens and the risk of breast, endometrial, and ovarian cancers.
Brown SB; Hankinson SE
Steroids; 2015 Jul; 99(Pt A):8-10. PubMed ID: 25555473
[TBL] [Abstract][Full Text] [Related]
11. Circulating steroid hormone levels and risk of breast cancer for postmenopausal women.
Baglietto L; Severi G; English DR; Krishnan K; Hopper JL; McLean C; Morris HA; Tilley WD; Giles GG
Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):492-502. PubMed ID: 20086116
[TBL] [Abstract][Full Text] [Related]
12. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
[TBL] [Abstract][Full Text] [Related]
13. Comparison of hormone levels in nipple aspirate fluid of pre- and postmenopausal women: effect of oral contraceptives and hormone replacement.
Chatterton RT; Geiger AS; Mateo ET; Helenowski IB; Gann PH
J Clin Endocrinol Metab; 2005 Mar; 90(3):1686-91. PubMed ID: 15572416
[TBL] [Abstract][Full Text] [Related]
14. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE
J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642
[TBL] [Abstract][Full Text] [Related]
15. Case-control study of endogenous sex steroid hormones and risk of endometrial cancer.
Friedenreich CM; Derksen JWG; Speidel T; Brenner DR; Heer E; Courneya KS; Cook LS
Cancer Causes Control; 2020 Feb; 31(2):161-171. PubMed ID: 31865473
[TBL] [Abstract][Full Text] [Related]
16. Serum sex hormones and breast cancer risk factors in postmenopausal women.
Lamar CA; Dorgan JF; Longcope C; Stanczyk FZ; Falk RT; Stephenson HE
Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):380-3. PubMed ID: 12692114
[TBL] [Abstract][Full Text] [Related]
17. Alcohol and endogenous sex steroid levels in postmenopausal women: a cross-sectional study.
Onland-Moret NC; Peeters PH; van der Schouw YT; Grobbee DE; van Gils CH
J Clin Endocrinol Metab; 2005 Mar; 90(3):1414-9. PubMed ID: 15572431
[TBL] [Abstract][Full Text] [Related]
18. Androgens and estrogens in postmenopausal insulin-treated diabetic women.
Nyholm H; Djursing H; Hagen C; Agner T; Bennett P; Svenstrup B
J Clin Endocrinol Metab; 1989 Nov; 69(5):946-9. PubMed ID: 2677038
[TBL] [Abstract][Full Text] [Related]
19. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
Stomati M; Monteleone P; Casarosa E; Quirici B; Puccetti S; Bernardi F; Genazzani AD; Rovati L; Luisi M; Genazzani AR
Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
[TBL] [Abstract][Full Text] [Related]
20. Doubts about oestrogen therapy in postmenopausal women.
Res Reprod; 1976 Jan; 8(1):1-2. PubMed ID: 12258712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
